This is a delivery order awarded by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The order is for 4,565,350 units of the M-M-R II vaccine, a critical medical product used to prevent measles, mumps, and rubella. The fixed-price contract has a ceiling value of $14,081.38 and an ultimate completion date of August 6, 2024. This award is not associated with any set-aside program. Amerisourcebergen, as a large for-profit organization, has been providing a wide range of pharmaceutical and medical supplies to support various federal agencies and healthcare programs, including the military and veterans' facilities. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to deliver a comprehensive range of essential medical commodities.
Generated 11/4/24, 11:52 AM